SKOKIE, Ill.--(BUSINESS WIRE)--Midwest BioResearch, LLC (MBR) today announced that rapid company growth has necessitated a move to a new facility: ironically, the former Pfizer/Pharmacia/Searle site where many of MBR’s colleagues once worked. Fueling the company’s expansion is a marked increase in demand for its drug disposition and toxicology services at all stages of drug research and development, a sign of the overall good health of the outsourcing industry.
